 | • レポートコード：TPM-B04471 • 出版社/出版日：Transparency Market Research / 2018年1月 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、不眠症の世界市場について調べ、不眠症の世界規模、市場動向、市場環境、治療種類別分析、販売経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・不眠症の世界市場動向 ・不眠症の世界市場環境 ・不眠症の世界市場規模 ・不眠症の世界市場規模：治療種類別 ・不眠症の世界市場規模：販売経路別 ・不眠症の世界市場：地域別市場規模・分析 ・不眠症の北米市場規模・予測 ・不眠症のアメリカ市場規模・予測 ・不眠症の中南米市場規模・予測 ・不眠症のヨーロッパ市場規模・予測 ・不眠症のアジア市場規模・予測 ・不眠症の日本市場規模・予測 ・不眠症の中国市場規模・予測 ・不眠症のインド市場規模・予測 ・不眠症のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
According to the Sleep Health Foundation, Insomnia has been estimated to affect over one-third of the global population. Insomnia is characterized on the basis of multiple patterns such as difficulty in sleep initiation & maintenance that is usually accompanied with awakening too early & trouble sleeping again or frequent awakenings. Long-term insomnia has impacted daily life of individuals suffering from the disease, and has been associated with nervous breakdown or severe depression if left untreated. Increasing presence of patented molecules and potential clinical pipeline drug candidates hold promise in the treatment of insomnia. Demand for insomnia therapeutics will witness a tremendous rise on the back of growing geriatric population, and rising stress level among the urban population.
Transparency Market Research (TMR) has published a new insightful report on the global insomnia market. The report delivers forecasts on the global insomnia market, and examines the market in detail, providing important dynamics affecting the market expansion. Along with the provision of information on latest market trends, restraining factors, and augmenting factors impacting growth of the market, analysis on the data regarding multiple market parameters has been included in the report.
Report Structure
The report’s initiates with a chapter titled “executive summary”, which issues a summation of global insomnia market coupled with the information on imperative market numbers such as historical CAGR (2012-2016) and forecast CAGR (2017-2026). These numbers rendered are associated with the market segments incorporated in the report. Trailing the executive summary is a chapter titled “overview” that incorporates the definition of “insomnia”, which succeeds an incisive market introduction. The overview chapter clearly describes the wide scope of global insomnia market. Some chapters in the report offer information on the pricing analysis coupled with the cost structure regarding the global insomnia market.
Competition Landscape
A scrupulous analysis regarding the global insomnia market’s competition landscape has been issued in the concluding chapter of this report, incorporating information on prominent industries that significantly contribute to the market expansion. Occupancy of these market participants is tracked with the aid of an intensity map. Profiling key market participants rigorously, this chapter offers insights based on SWOT analysis, key developments, key financials, company overview, and product overview.
Research Methodology
A robust research methodology, proven & tested, has been employed by TMR’s analysts to develop the report on global insomnia market. The research methodology used has helped analysts in offering accurate insights related to the global insomnia market. It depends entirely upon the secondary and primary researches, for gaining important information associated with the market. The information compiled has then been validated by the analysts several times for ensuring the report’s authenticity, and for making it a reliable & authoritative source of reference for readers of the report.
レポート目次1. Global Economic Outlook
2. Global Insomnia Market – Executive Summary
3. Global Insomnia Market Overview
3.1. Introduction
3.1.1. Global Insomnia Market Taxonomy
3.1.2. Global Insomnia Market Definition
3.2. Global Insomnia Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Insomnia Market Y-o-Y Growth
3.3. Global Insomnia Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. Product Life Cycle
3.8. PESTLE Analysis
3.9. List of Distributors
4. Global Insomnia Market Analysis and Forecast 2012-2026
4.1. Global Insomnia Market Size and Forecast By Treatment Type, 2012-2026
4.1.1. Benzodiazepines Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Nonbenzodiazepines Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Antidepressants Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Orexin Antagonist Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Melatonin Antagonist Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.1.6. Devices Market Size and Forecast, 2012-2026
4.1.6.1. Revenue (US$ Mn) Comparison, By Region
4.1.6.2. Market Share Comparison, By Region
4.1.6.3. Y-o-Y growth Comparison, By Region
4.1.7. Other Treatment Types Market Size and Forecast, 2012-2026
4.1.7.1. Revenue (US$ Mn) Comparison, By Region
4.1.7.2. Market Share Comparison, By Region
4.1.7.3. Y-o-Y growth Comparison, By Region
4.2. Global Insomnia Market Size and Forecast By Sales Channel, 2012-2026
4.2.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Retail Pharmacies and Drug Stores Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Online Pharmacies Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
5. North America Insomnia Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Treatment Type
5.6. Revenue (US$ Mn) Comparison, By Sales Channel
6. Latin America Insomnia Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Treatment Type
6.6. Revenue (US$ Mn) Comparison, By Sales Channel
7. Europe Insomnia Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Treatment Type
7.6. Revenue (US$ Mn) Comparison, By Sales Channel
8. Japan Insomnia Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Treatment Type
8.6. Revenue (US$ Mn) Comparison, By Sales Channel
9. APEJ Insomnia Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Treatment Type
9.6. Revenue (US$ Mn) Comparison, By Sales Channel
10. MEA Insomnia Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Treatment Type
10.6. Revenue (US$ Mn) Comparison, By Sales Channel
11. Global Insomnia Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
11.3.1. Merck & Co Company
11.3.2. Sanofi
11.3.3. Pfizer Inc.
11.3.4. Takeda Pharmaceutical Company Limited
11.3.5. Vanda Pharmaceuticals Inc.
11.3.6. Mylan N.V.
11.3.7. Teva Pharmaceutical Industries Limited
11.3.8. Sumitomo Dainippon Pharma Co., Ltd.
11.3.9. Paratek Pharmaceuticals, Inc.
11.3.10. Pernix Therapeutics Holdings, Inc.
12. Research Methodology
13. Secondary and Primary Sources
14. Assumptions and Acronyms
15. Disclaimer
List Of TableTABLE 1 Global Insomnia Market Value (US$ Mn), 2012-2017
TABLE 2 Global Insomnia Market Value (US$ Mn), 2018-2026
TABLE 3 Global Insomnia Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Benzodiazepines Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Benzodiazepines Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Benzodiazepines Segment Market Share, By Region 2012-2017
TABLE 7 Global Benzodiazepines Segment Market Share, By Region 2018-2026
TABLE 8 Global Benzodiazepines Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Nonbenzodiazepines Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Nonbenzodiazepines Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Nonbenzodiazepines Segment Market Share, By Region 2012-2017
TABLE 12 Global Nonbenzodiazepines Segment Market Share, By Region 2018-2026
TABLE 13 Global Nonbenzodiazepines Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Antidepressants Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Antidepressants Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Antidepressants Segment Market Share, By Region 2012-2017
TABLE 17 Global Antidepressants Segment Market Share, By Region 2018-2026
TABLE 18 Global Antidepressants Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Orexin Antagonist Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Orexin Antagonist Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Orexin Antagonist Segment Market Share, By Region 2012-2017
TABLE 22 Global Orexin Antagonist Segment Market Share, By Region 2018-2026
TABLE 23 Global Orexin Antagonist Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Melatonin Antagonist Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Melatonin Antagonist Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Melatonin Antagonist Segment Market Share, By Region 2012-2017
TABLE 27 Global Melatonin Antagonist Segment Market Share, By Region 2018-2026
TABLE 28 Global Melatonin Antagonist Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Devices Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Devices Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Devices Segment Market Share, By Region 2012-2017
TABLE 32 Global Devices Segment Market Share, By Region 2018-2026
TABLE 33 Global Devices Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Other Treatment Types Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Other Treatment Types Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Other Treatment Types Segment Market Share, By Region 2012-2017
TABLE 37 Global Other Treatment Types Segment Market Share, By Region 2018-2026
TABLE 38 Global Other Treatment Types Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 42 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 43 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2012-2017
TABLE 47 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2018-2026
TABLE 48 Global Retail Pharmacies and Drug Stores Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 52 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 53 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 54 North America Insomnia Market Value (US$ Mn), By Country 2012-2017
TABLE 55 North America Insomnia Market Value (US$ Mn), By Country 2018-2026
TABLE 56 North America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 57 North America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 58 North America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 59 North America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 60 Latin America Insomnia Market Value (US$ Mn), By Country 2012-2017
TABLE 61 Latin America Insomnia Market Value (US$ Mn), By Country 2018-2026
TABLE 62 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 63 Latin America Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 64 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 65 Latin America Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 66 Europe Insomnia Market Value (US$ Mn), By Country 2012-2017
TABLE 67 Europe Insomnia Market Value (US$ Mn), By Country 2018-2026
TABLE 68 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 69 Europe Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 70 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 71 Europe Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 72 Japan Insomnia Market Value (US$ Mn), By Country 2012-2017
TABLE 73 Japan Insomnia Market Value (US$ Mn), By Country 2018-2026
TABLE 74 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 75 Japan Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 76 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 77 Japan Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 78 APEJ Insomnia Market Value (US$ Mn), By Country 2012-2017
TABLE 79 APEJ Insomnia Market Value (US$ Mn), By Country 2018-2026
TABLE 80 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 81 APEJ Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 82 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 83 APEJ Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026
TABLE 84 MEA Insomnia Market Value (US$ Mn), By Country 2012-2017
TABLE 85 MEA Insomnia Market Value (US$ Mn), By Country 2018-2026
TABLE 86 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 87 MEA Insomnia Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 88 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2012-2017
TABLE 89 MEA Insomnia Market Value (US$ Mn), By Sales Channel 2018-2026